Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.3T | 1.2T | 1.4T | 1.2T |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 629.0B | 600.2B | 580.3B | 592.4B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 87.5B | 585.0B | 509.2B | 518.2B |
Tax provision | 43.0B | 172.5B | 152.8B | 144.8B |
Net income | 44.5B | 412.6B | 356.4B | 373.4B |
Basic EPS | — | — | — | 56.6 |
Diluted EPS | — | — | — | 56.6 |
Basic average shares | — | — | — | 6.6B |
Diluted average shares | — | — | — | 6.6B |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -2.4B | -1.8B | -2.6B | -2.0B |
Preferred stock dividends | — | — | — | — |